Classic Psychedelic Drugs: Update on Biological Mechanisms

This comprehensive review article (2022) explores the neurobiological mechanisms through which psychedelics exert their effects in light of recent research. The pharmacological and neuroplastic effects are discussed as well as the hypothesized functional network models of psychedelic states. How these psychedelic states correlate with altered self- and emotion-processing is also explored.

Abstract

“Renewed interest in the effects of psychedelics in the treatment of psychiatric disorders warrants a better understanding of the neurobiological mechanisms underlying the effects of these substances. During the past two decades, state-of-the-art studies of animals and humans have yielded new important insights into the molecular, cellular, and systems-level actions of psychedelic drugs. These efforts have revealed that psychedelics affect primarily serotonergic receptor subtypes located in cortico-thalamic and cortico-cortical feedback circuits of information processing. Psychedelic drugs modulate excitatory-inhibitory balance in these circuits and can participate in neuroplasticity within brain structures critical for the integration of information relevant to sensation, cognition, emotions, and the narrative of self. Neuroimaging studies showed that characteristic dimensions of the psychedelic experience obtained through subjective questionnaires as well as alterations in self-referential processing and emotion regulation obtained through neuropsychological tasks are associated with distinct changes in brain activity and connectivity patterns at multiple-system levels. These recent results suggest that changes in self-experience, emotional processing, and social cognition may contribute to the potential therapeutic effects of psychedelics.”

Authors: Franz X. Vollenweider & John W. Smallridge

Find this paper

Classic Psychedelic Drugs: Update on Biological Mechanisms

https://doi.org/%2010.1055/a-1721-2914

Open Access | Google Scholar | Backup | 🕊

Published in
Pharmacopsychiatry
January 27, 2022
0 citations

Study details

Topics studied
Neuroscience

Study characteristics
Literature Review

Authors

Authors associated with this publication with profiles on Blossom

Franz Vollenweider
Franz X. Vollenweider is one of the pioneering psychedelics researchers, currently at the University of Zurich. He is also the director of the Heffter (sponsored) Research Center Zürich for Consciousness Studies (HRC-ZH).

Institutes

Institutes associated with this publication

University of Zurich
Within the Department of Psychiatry, Psychotherapy and Psychosomatics at the University of Zurich, Dr Mialn Scheidegger is leading team conducting psychedelic research and therapy development.